This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting to consider Q1 FY27 results deferred
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.4 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide has postponed the board meeting originally scheduled for August 3, 2026, which was meant to consider and approve unaudited financial results for the quarter ended June 30, 2026. The company cited unavoidable circumstances for the deferment and said a revised date will be announced later. The trading window for designated persons remains closed until 48 hours after the results are declared.
Short-term uncertainty as Q1 results are delayed. No financial numbers shared yet, so impact on the stock is limited until the new date is set.
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹96.07 Cr | ₹66.66 Cr | +44.1% |
| Operating profit | ₹6.71 Cr | −₹0.67 Cr | turned positive |
| Profit after tax | ₹6.61 Cr | ₹0.89 Cr | +642.3% |
| EBITDA margin | 12.7% | 7.2% | +5.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.